Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 2Stomach Neoplasms 2Rectal Neoplasms 2Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Colonic Neoplasms 1Breast Neoplasms 1Anus Neoplasms 1

Interventions

fludarabine 4aldesleukin 4Cyclophosphamide 4pembrolizumab 3fludarabine phosphate 2Taxes 2Radiotherapy 2Polymerase Chain Reaction 2Nicotine 2Gene Expression Profiling 2Fluorodeoxyglucose F18 2Counseling 2Cisplatin 2Bupropion 2Biopsy 2Adoptive Transfer 2motexafin gadolinium 1fluoromisonidazole 1entinostat 1durvalumab 1bintrafusp alfa protein, human 1Zinc Oxide 1Varenicline 1Tomography, X-Ray Computed 1Tobacco Use Cessation Devices 1Surgical Procedures, Operative 1Sucralfate 1Salts 1Rubidium-82 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Oropharyngeal Neoplasms × Diphenhydramine × Gastrointestinal × Clear all
NCT04432597 2026-05-18

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
39 enrolled
GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡